ClinPharm Consulting Launches Populat...

ClinPharm Consulting Launches Population Pharmacokinetics Service

Posted in the Apex Forum

Since: Jul 10

Chapel Hill, NC

#1 Nov 3, 2010
(Research Triangle Park, N.C.) ClinPharm Consulting, a specialized consulting firm offering a unique paradigm for empowering drug development pipelines, has added Giulia Ghibellini, Ph.D. to its team of credentialed industry veterans to implement a new population pharmacokinetics service.

Population PK modeling is an integral part of drug development and is typically conducted within or across large studies (e.g., Phase 2 and 3) to explain variability by identifying factors that may influence the pharmacokinetic behavior of an investigational drug.

For more information on ClinPharm Consulting services, email [email protected] om or visit .

ClinPharm Consulting is a specialized consulting firm offering a unique paradigm for empowering drug development pipelines. Our business model focuses on matching scientific and pharmacokinetic/pharmacodynami c expertise with superior writing capabilities to maximize the impact of individual studies on an overall clinical pharmacology program. We specialize in helping small biopharmaceutical companies with minimal R&D infrastructure find scalable solutions for emerging early phase drug development challenges, providing an unmatched combination of technical expertise and robust understanding of clinical pharmacology from a scientific, regulatory and clinical conduct perspective.
The breadth of our experience allows ClinPharm Consulting to be a complete resource for clients to set up their drug development programs for success. ClinPharm Consulting typically engages clients as early as the IND planning stage to develop robust clinical pharmacology strategies and then works as a horizontally integrated, in-house resource to assist with the execution and analysis of those strategies. Our efforts not only include the design, conduct, and analysis of clinical pharmacology studies but also helping clients transition from nonclinical research into early phase clinical trials as well as transitioning from healthy volunteers into patients with the target disease.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Apex Discussions

Title Updated Last By Comments
snitches in durham nc. (Dec '11) Jul 11 Mike 6
News The Thread: The 6.25.17 Issue Jul 8 Shirvell s Shrivel 6
News Together, Triangle Transit Agencies Seek Federa... Jul 2 Macmcf 1
Beware Mike Luchansky (Aug '10) Jun 30 Guilty Guilty Guilty 73
Sarah boring aka Sarah morgan...aka sarah the s... Jun 24 Cuz I can 1
sarah boring Apr '17 u dont wanna know me 3
sue Mar '17 cuz i fookin can 2

Apex Jobs

More from around the web

Personal Finance

Apex Mortgages